Autoimmune hemolytic anaemia in the antiphospholipid syndrome

Lupus

Volumn 15, Issue 7, 2006, Pages 473-477

  Rottem, M ^a,b   Krause, I ^c,d   Fraser, A ^d   Stojanovich, L ^e   Rovensky, J ^f   Shoenfeld, Y ^c,d  

^a HaEmek Medical Center   (Serbia)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

^e INSTITUTE OF RHEUMATOLOGY   (Serbia)

^f NATIONAL INSTITUTE OF RHEUMATIC DISEASES   (Slovakia)

Author keywords

Anti phospholipid syndrome; Autoimmune hemolytic anaemia; Thrombosis

Indexed keywords

CARDIOLIPIN ANTIBODY;

ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; CENTRAL NERVOUS SYSTEM; CHOREA; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; EPILEPSY; FEMALE; HEART VALVE; HUMAN; ISRAEL; LIVEDO RETICULARIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PREGNANCY OUTCOME; PRIORITY JOURNAL; SLOVAKIA; YUGOSLAVIA;

EID: 33746628584     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203306lu2336oa     Document Type: Article

References (23)

1. Naguwa S, Robbins DL. Rheumatological disorders. In Delves PJ, Roitt IM eds. Encyclopedia of immunology, 2nd edition. Academic Press, 1998: 2118.
2. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002; 346: 752-763.
3. Shoenfeld Y. Systemic antiphospholipid syndrome. Lupus 2003; 12: 497-498.
4. Schreiber AD. Autoimmune hemolyitic anaemia. In Austen KF, Frank MM, Atkinson JP, Cantor H eds. Samter's immunologic diseases, 6th edition. Lippinkot Williams & Wilkins, 2001: 738-749.
5. Gehrs BC, Friedberg RC. Autoimmune hemolytic anaemia. Am J Hematol 2002; 69: 258-271.
6. Gomez-Puerta JA, Martin H, Amigo MC et al. Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus? Medicine (Baltimore) 2005; 84: 225-230.
7. Girardi G, Herman J, Redecha P et al. Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest 2003; 112: 1644-1654.
8. Kumar V, Ali SR, Konrad S et al. Cell-derived anaphylatoxins as key mediators of antibody-dependent type II autoimmunity in mice. J Clin Invest 2006; 116: 512.
9. Erdozain JG, Ruiz-Irastorza G, Egurbide MV, Aguirre C. Sustained response to rituximab of autoimmune hemolytic anaemia associated with antiphospholipid syndrome. Haematologica 2004; 89: ECR34.
10. Alba P, Karim MY, Hunt BJ. Mycophenolate mofetil as a treatment for autoimmune hemolytic anaemia in patients with systemic lupus erythematosus and antiphospholipid syndrome. Lupus 2003; 12: 633-635.
11. Wilson WA, Gharavi AE, Koike T et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 42: 1309-1311.
12. Whisnant JP. Special report from the National Institute of Neurologic Disorder and Stroke. Classification of cerebrovascular diseases. Stroke 1990; 21: 637-676.
13. The Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of Epileptic seizures. Epilepsia 1981; 22: 489-501.
14. Finazzi G, Brancaccio V, Moia M et al. Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies. A four year prospective study from the Italian Registry. Am J Med 1996; 100: 530-536.
15. Latagliata R, Celesti F, Bongarzoni V et al. Intracardiac thrombus in a patient with autoimmune hemolytic anaemia leading to a diagnosis of antiphospholipid syndrome. Acta Haematol 2002; 107: 170-172.
16. Toubi E, Krause I, Fraser A, Lev S, Blank M, Shoenfeld Y. Livedo reticularis is a marker for predicting multi-system thrombosis in antiphospholipid syndrome. Clin Exp Rheumatol 2005; 23: 499-504.
17. Lev S, Shoenfeld Y. Cardiac valvulopathy in the antiphospholipid syndrome. Clin Rev Allergy Immunol 2002; 23: 341-348.
18. Nesher G, Ilany J, Rosenmann D, Abraham AS. Valvular dysfunction in antiphospholipid syndrome: prevalence, clinical features, and treatment. Semin Arthritis Rheum 1997; 27: 27-35.
19. Hojnik M, George J, Ziporen L, Shoenfeld Y. Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation 1996; 93: 1579-1587.
20. Ziporen L, Goldberg I, Arad M et al. Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves. Lupus 1996; 5: 196-205.
21. Shoenfeld Y, Lev S, Blatt I et al. Features associated with epilepsy in the antiphospholipid syndrome. J Rheumatol 2004; 31: 1344-1348.
22. Kokori SI, Ioannidis JP, Voulgarelis M, Tzioufas AG, Moutsopoulos HM. Autoimmune hemolytic anaemia in patients with systemic lupus erythematosus. Am J Med 2000; 108: 198-204.
23. Sthoeger Z, Sthoeger D, Green L, Geltner D. The role of anticardiolipin autoantibodies in the pathogenesis of autoimmune hemolytic anaemia in systemic lupus erythematosus. J Rheumatol 1993; 20: 2058-2061.